SAN DIEGO—During ACR Convergence 2023 in November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the recipients of the ARP President’s Awards. The ARP president can choose to honor ACR/ARP members or teams performing outstanding…
Originally posted Feb. 13, 2023; reposted in conjunction with publication of the PMR supplement to the February 2024 issue of The Rheumatologist. PHILADELPHIA—Polymyalgia rheumatica (PMR) is a chronic inflammatory condition that almost exclusively affects individuals older than 50.1 First described in 1888, PMR has been a recognized rheumatic disease since at least 1957. Diagnosing the…
The program will take place May 5–7 in conjunction with the ACR Advocacy Leadership Conference in Washington, DC. Fellows in training, program directors and ARP members passionate about advocacy and governance are especially encouraged to apply
After three years on the Committee for Research, Linda Hiraki, MD, ScD, has stepped into the role of chair. During her term, she aims to foster global connections to advance and expand the positive impact of rheumatology research.
Liana Fraenkel, MD, MPH, credits much of her own career success to support from the Foundation, and she is eager to advance its mission during her presidency.
SAN DIEGO—At ACR Convergence 2023, panelists presented information concerning several policy issues that affect rheumatologists & their patients, including abortion access & the WHO’s Essential Medicine List.
At ACR Convergence 2023, panelists presented information concerning several policy issues that affect rheumatologists & their patients, including abortion access & the WHO’s Essential Medicine List.
This year’s matching campaign raised more than $20,000 from ACR and ARP members and staff and another $7,300 from volunteer leaders.
SAN DIEGO—In an advocacy update session at ACR Convergence 2023, ACR staff described progress in multiple priority areas, including access to care and workforce issues.
Deborah Dyett Desir, MD is the 87th ACR president and the first Black person elected to the position. In conversation with The Rheumatologist, this profile follows her career from academic research to private practice to Yale faculty & the ACR presidency.